DISHMAN CARBOGEN AMCIS
Back to Income Statement
|
DISHMAN CARBOGEN AMCIS Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹2,616 Cr | ₹2,413 Cr | ₹2,141 Cr | ₹1,912 Cr | ₹2,044 Cr |
What is the latest Revenue of DISHMAN CARBOGEN AMCIS ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹2,616 Cr |
| Mar2024 | ₹2,413 Cr |
| Mar2023 | ₹2,141 Cr |
| Mar2022 | ₹1,912 Cr |
| Mar2021 | ₹2,044 Cr |
How is Revenue of DISHMAN CARBOGEN AMCIS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,616 Cr | 8.41 | |
| Mar2024 | ₹2,413 Cr | 12.72 | |
| Mar2023 | ₹2,141 Cr | 11.96 | |
| Mar2022 | ₹1,912 Cr | -6.44 | |
| Mar2021 | ₹2,044 Cr | - | |
Compare Revenue of peers of DISHMAN CARBOGEN AMCIS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DISHMAN CARBOGEN AMCIS | ₹2,413.9 Cr | -4% | -15.3% | -37.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,645.0 Cr | 2.9% | 3.6% | 0.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,625.0 Cr | 0.6% | -4.5% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,415.0 Cr | 2.1% | -0.4% | 31.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,664.0 Cr | 2.2% | -0.4% | 6.2% | Stock Analytics | |
| CIPLA | ₹100,480.0 Cr | 0.4% | -6.2% | -19.4% | Stock Analytics | |
DISHMAN CARBOGEN AMCIS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DISHMAN CARBOGEN AMCIS | -4% |
-15.3% |
-37.2% |
| SENSEX | -1.9% |
-9.1% |
-0.2% |
You may also like the below Video Courses